Guidance on batch testing medicines and other health issues if there's no Brexit deal
|
If the UK leaves the EU in March 2019 without a deal, we’ll
continue to: accept batch testing of human medicines carried out in
countries on a list from the Medicines and Healthcare products
Regulatory Agency (MHRA) require a UK, EU or EEA-based qualified
person (QP) to certify batch testing Download: Batch testing
medicines if...Request free trial
If the UK leaves the EU in March 2019 without a deal, we’ll continue to:
Download: Batch testing
medicines if there’s no Brexit deal Matt Hancock writes to health and care system on no-deal Brexit planning Matt Hancock has told staff that patients will continue to have access to medicines, medical products and high-quality care in the unlikely event of a no-deal Brexit. In his letter to NHS staff, the Health and Social Care Secretary says:
Read the full text of the letter from Matt Hancock to NHS staff. DHSC publishes Brexit guidance for pharmaceutical industry and suppliers of medical devices The Health and Social Care Secretary has written 2 letters to industry about contingency plans in the unlikely event of a no-deal Brexit. In his letter to pharmaceutical companies (PDF, 65.9KB, 3 pages) Matt Hancock asks suppliers to:
In his letter to suppliers of medical devices and clinical consumables (PDF, 62.3KB, 2 pages) he says that:
Six technical notices relating to health have been published by the government, covering:
If the UK leaves the EU with no deal:
|